These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 7933708)
1. The direct effect of lithium and carbamazepine on protein kinase C in rat brain. Morishita S; Watanabe S Jpn J Psychiatry Neurol; 1994 Mar; 48(1):123-6. PubMed ID: 7933708 [TBL] [Abstract][Full Text] [Related]
2. Altered protein phosphorylation in the rat brain following chronic lithium and carbamazepine treatments. Jensen JB; Mørk A Eur Neuropsychopharmacol; 1997 Aug; 7(3):173-9. PubMed ID: 9213075 [TBL] [Abstract][Full Text] [Related]
3. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain? Lenox RH; McNamara RK; Watterson JM; Watson DG J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of long-term lithium and carbamazepine administration on Gs alpha and Gi alpha protein in rat brain. Lesch KP; Aulakh CS; Tolliver TJ; Hill JL; Wolozin BL; Murphy DL Eur J Pharmacol; 1991 Aug; 207(4):355-9. PubMed ID: 1783003 [TBL] [Abstract][Full Text] [Related]
5. Mood stabilizers: shared mechanisms of action at postsynaptic signal-transduction and kindling processes. Stoll AL; Severus WE Harv Rev Psychiatry; 1996; 4(2):77-89. PubMed ID: 9384977 [TBL] [Abstract][Full Text] [Related]
6. GABA receptor alterations after chronic lithium administration. Comparison with carbamazepine and sodium valproate. Motohashi N Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jul; 16(4):571-9. PubMed ID: 1322549 [TBL] [Abstract][Full Text] [Related]
7. Mood stabilizers inhibit glucocorticoid receptor function in LMCAT cells. Basta-Kaim A; Budziszewska B; Jaworska-Feil L; Tetich M; Kubera M; Leśkiewicz M; Lasoń W Eur J Pharmacol; 2004 Jul; 495(2-3):103-10. PubMed ID: 15249158 [TBL] [Abstract][Full Text] [Related]
8. Modulation of carbachol-stimulated AP-1 DNA binding activity by therapeutic agents for bipolar disorder in human neuroblastoma SH-SY5Y cells. Pacheco MA; Jope RS Brain Res Mol Brain Res; 1999 Oct; 72(2):138-46. PubMed ID: 10529472 [TBL] [Abstract][Full Text] [Related]
9. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385 [TBL] [Abstract][Full Text] [Related]
10. Myo-inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate. Vadnal R; Parthasarathy R Neuropsychopharmacology; 1995 Jul; 12(4):277-85. PubMed ID: 7576004 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect. Mann L; Heldman E; Bersudsky Y; Vatner SF; Ishikawa Y; Almog O; Belmaker RH; Agam G Bipolar Disord; 2009 Dec; 11(8):885-96. PubMed ID: 19922557 [TBL] [Abstract][Full Text] [Related]
12. Selective effects of long-term lithium and carbamazepine administration on G-protein subunit expression in rat brain. Jakobsen SN; Wiborg O Brain Res; 1998 Jan; 780(1):46-55. PubMed ID: 9473582 [TBL] [Abstract][Full Text] [Related]
13. Regulation of signal transduction pathways by mood-stabilizing agents: implications for the delayed onset of therapeutic efficacy. Manji HK; Chen G; Hsiao JK; Risby ED; Masana MI; Potter WZ J Clin Psychiatry; 1996; 57 Suppl 13():34-46; discussion 47-8. PubMed ID: 8970503 [TBL] [Abstract][Full Text] [Related]
14. [Effect of lithium, carbamazepine, and setiptiline on diacylglycerol in rat brain ex vivo]. Kodama H Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Feb; 14(1):33-8. PubMed ID: 8048280 [TBL] [Abstract][Full Text] [Related]
15. Region-selective effects of long-term lithium and carbamazepine administration on cyclic AMP levels in rat brain. Wiborg O; Krüger T; Jakobsen SN Pharmacol Toxicol; 1999 Feb; 84(2):88-93. PubMed ID: 10068152 [TBL] [Abstract][Full Text] [Related]
16. Molecular cloning of a novel isoform of diphosphoinositol polyphosphate phosphohydrolase: a potential target of lithium therapy. Hua LV; Green M; Warsh JJ; Li PP Neuropsychopharmacology; 2001 Jun; 24(6):640-51. PubMed ID: 11331144 [TBL] [Abstract][Full Text] [Related]
17. In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3. Gould TD; Chen G; Manji HK Neuropsychopharmacology; 2004 Jan; 29(1):32-8. PubMed ID: 12942141 [TBL] [Abstract][Full Text] [Related]
18. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. Kowatch RA; Suppes T; Carmody TJ; Bucci JP; Hume JH; Kromelis M; Emslie GJ; Weinberg WA; Rush AJ J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):713-20. PubMed ID: 10846305 [TBL] [Abstract][Full Text] [Related]
19. Differential effect of lithium on fos protooncogene expression mediated by receptor and postreceptor activators of protein kinase C and cyclic adenosine monophosphate: model for its antimanic action. Divish MM; Sheftel G; Boyle A; Kalasapudi VD; Papolos DF; Lachman HM J Neurosci Res; 1991 Jan; 28(1):40-8. PubMed ID: 1674966 [TBL] [Abstract][Full Text] [Related]
20. Actions of lithium on the cyclic AMP signalling system in various regions of the brain--possible relations to its psychotropic actions. A study on the adenylate cyclase in rat cerebral cortex, corpus striatum and hippocampus. Mørk A Pharmacol Toxicol; 1993; 73 Suppl 3():1-47. PubMed ID: 8146086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]